INSL3 and thyroid cancer: This result seemed to be believable because in vitro and in vivo studies on thyroid cancer demonstrated that recombinant and secreted INSL3 increased the motility and growth of thyroid carcinoma cells and enhanced the formation of fast-growing and highly vascularized xenografts in nude mice [35].